Drug:
Reaction: GENERAL PHYSICAL HEALTH DETERIORATION
20260101 - 20261231
No. 501 - 600
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 501 | 26465723 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 DOTATATE, |
||||
| 502 | 26465794 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 503 | 26465835 |
US |
63 | 2 |
General physical health deterioration, Pain, |
||||
ABATACEPT, |
||||
| 504 | 26465947 |
EU |
78 | 2 |
Chest pain, General physical health deterioration, Asthenia, |
||||
EVOLOCUMAB, |
||||
| 505 | 26466054 |
CA |
30 | 1 |
Colitis ulcerative, General physical health deterioration, Rectal haemorrhage, Diarrhoea, |
||||
PEMETREXED DISODIUM, NIVOLUMAB, IPILIMUMAB, |
||||
| 506 | 26466122 |
US |
4 | 2 |
Seizure, Abdominal discomfort, General physical health deterioration, Irritability, Product size issue, |
||||
TROFINETIDE, TROFINETIDE, |
||||
| 507 | 26466128 |
EU |
72 | 1 |
Hallucination, Anger, General physical health deterioration, Hypophagia, Musculoskeletal stiffness, Pain, Unevaluable event, Drug ineffective, Overdose, |
||||
CLOZAPINE, HYDROXYZINE, RIVASTIGMINE, |
||||
| 508 | 26466196 |
US |
1 | |
Dementia, Parkinson^s disease, Gait inability, General physical health deterioration, |
||||
PIMAVANSERIN TARTRATE, DROXIDOPA, |
||||
| 509 | 26466261 |
US |
55 | 2 |
Muscle spasms, Respiratory tract congestion, Gastrointestinal sounds abnormal, Cough, General physical health deterioration, Crohn^s disease, Fatigue, Asthenia, Rhinorrhoea, Abdominal distension, Off label use, |
||||
RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, |
||||
| 510 | 26466497 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 511 | 26466536 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 512 | 26466638 |
CA |
40 | 2 |
Abdominal discomfort, Abdominal distension, Abdominal pain upper, Alopecia, Arthralgia, Arthropathy, Asthenia, Back injury, Blepharospasm, Blister, Breast cancer stage III, Bursitis, Coeliac disease, Condition aggravated, Confusional state, Contusion, Depression, Diarrhoea, Dizziness, Drug hypersensitivity, Drug-induced liver injury, Dry mouth, Duodenal ulcer perforation, Dyspepsia, Dyspnoea, Epilepsy, Facet joint syndrome, Fall, Fatigue, Fibromyalgia, Finger deformity, Folliculitis, Gait inability, Gastrointestinal disorder, Gastrooesophageal reflux disease, General physical health deterioration, Glossodynia, Hand deformity, Headache, Helicobacter infection, Hepatitis, Hypercholesterolaemia, Hypersensitivity, Hypertension, Hypoaesthesia, Hypotension, Impaired healing, Inflammation, Infusion related reaction, Injection site reaction, Injury, Insomnia, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Lip dry, Liver injury, Lower respiratory tract infection, Lung disorder, Malaise, Memory impairment, Migraine, Mobility decreased, Muscle injury, Muscle spasms, Muscular weakness, Musculoskeletal pain, Musculoskeletal stiffness, Nail disorder, Nasopharyngitis, Nausea, Neck pain, Night sweats, Obesity, Onychomadesis, Onychomycosis, Osteoarthritis, Pain, Pain in extremity, Paraesthesia, Pemphigus, Pericarditis, Peripheral swelling, Peripheral venous disease, Pneumonia, Psoriatic arthropathy, Rash, Rheumatic fever, Rheumatoid arthritis, Sleep disorder, Stomatitis, Swelling, Synovitis, Systemic lupus erythematosus, Taste disorder, Type 2 diabetes mellitus, Urticaria, Vomiting, Wheezing, Wound, Wound infection, |
||||
TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, |
||||
| 513 | 26466677 |
US |
||
General physical health deterioration, Laboratory test abnormal, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 514 | 26466890 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 515 | 26466990 |
US |
78 | 2 |
General physical health deterioration, Hypokinesia, Tremor, |
||||
GALCANEZUMAB-GNLM, |
||||
| 516 | 26467065 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 517 | 26467227 |
CA |
80 | 2 |
Death, Abdominal distension, Abdominal pain, Activated partial thromboplastin time prolonged, Anaemia, Analgesic therapy, Antacid therapy, Anticoagulant therapy, Aortic stenosis, Appendicitis, Appendicolith, Ascites, Aspartate aminotransferase increased, Bacterial infection, Blood calcium increased, Blood cholesterol increased, Blood creatinine increased, Blood phosphorus increased, Blood test abnormal, Blood uric acid increased, Cardiogenic shock, Chronic obstructive pulmonary disease, Condition aggravated, Constipation, Diabetes mellitus, Drug hypersensitivity, Drug intolerance, Drug therapy, Dry mouth, Dyspnoea, End stage renal disease, General physical health deterioration, Gout, Hyperlipidaemia, Hyperphosphataemia, |
||||
ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ALLOPURINOL, ALLOPURINOL, ALLOPURINOL, DARBEPOETIN ALFA, DARBEPOETIN ALFA, DARBEPOETIN ALFA, DARBEPOETIN ALFA, DARBEPOETIN ALFA, DARBEPOETIN ALFA, DARBEPOETIN ALFA, DARBEPOETIN ALFA, DARBEPOETIN ALFA, DARBEPOETIN ALFA, DARBEPOETIN ALFA, DARBEPOETIN ALFA, DARBEPOETIN ALFA, IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, CALCITRIOL, CALCITRIOL CAPSULES 0.25 MCG, CALCITRIOL CAPSULES 0.5 MCG, CALCITRIOL, CALCITRIOL CAPSULES 0.25 MCG, CALCITRIOL CAPSULES 0.5 MCG, CALCITRIOL, CALCITRIOL CAPSULES 0.25 MCG, CALCITRIOL CAPSULES 0.5 MCG, CALCITRIOL, CALCITRIOL CAPSULES 0.25 MCG, CALCITRIOL CAPSULES 0.5 MCG, CALCITRIOL, CALCITRIOL CAPSULES 0.25 MCG, CALCITRIOL CAPSULES 0.5 MCG, CALCITRIOL, CALCITRIOL CAPSULES 0.25 MCG, CALCITRIOL CAPSULES 0.5 MCG, CALCITRIOL, CALCITRIOL CAPSULES 0.25 MCG, CALCITRIOL CAPSULES 0.5 MCG, CALCITRIOL, CALCITRIOL CAPSULES 0.25 MCG, CALCITRIOL CAPSULES 0.5 MCG, CEFTRIAXONE SODIUM, CEFTRIAXONE SODIUM, CEFTRIAXONE SODIUM, CEFTRIAXONE SODIUM, CEFTRIAXONE SODIUM, DEXLANSOPRAZOLE, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE, DALTEPARIN SODIUM, DALTEPARIN SODIUM, DALTEPARIN SODIUM, DALTEPARIN SODIUM, DALTEPARIN SODIUM, POLYETHYLENE GLYCOL (3350), POLYETHYLENE GLYCOL 3350, POLYETHYLENE GLYCOL 400, INSTALAX POLYETHYLENE GLYCOL 3350, POLYETHYLENE GLYCOL (3350), POLYETHYLENE GLYCOL 3350, POLYETHYLENE GLYCOL 400, INSTALAX POLYETHYLENE GLYCOL 3350, POLYETHYLENE GLYCOL (3350), POLYETHYLENE GLYCOL 3350, POLYETHYLENE GLYCOL 400, INSTALAX POLYETHYLENE GLYCOL 3350, POLYETHYLENE GLYCOL (3350), POLYETHYLENE GLYCOL 3350, POLYETHYLENE GLYCOL 400, INSTALAX POLYETHYLENE GLYCOL 3350, POLYETHYLENE GLYCOL (3350), POLYETHYLENE GLYCOL 3350, POLYETHYLENE GLYCOL 400, INSTALAX POLYETHYLENE GLYCOL 3350, POLYETHYLENE GLYCOL (3350), POLYETHYLENE GLYCOL 3350, POLYETHYLENE GLYCOL 400, INSTALAX POLYETHYLENE GLYCOL 3350, POLYETHYLENE GLYCOL (3350), POLYETHYLENE GLYCOL 3350, POLYETHYLENE GLYCOL 400, INSTALAX POLYETHYLENE GLYCOL 3350, POLYETHYLENE GLYCOL (3350), POLYETHYLENE GLYCOL 3350, POLYETHYLENE GLYCOL 400, INSTALAX POLYETHYLENE GLYCOL 3350, POLYETHYLENE GLYCOL (3350), POLYETHYLENE GLYCOL 3350, POLYETHYLENE GLYCOL 400, INSTALAX POLYETHYLENE GLYCOL 3350, POLYETHYLENE GLYCOL (3350), POLYETHYLENE GLYCOL 3350, POLYETHYLENE GLYCOL 400, INSTALAX POLYETHYLENE GLYCOL 3350, POLYETHYLENE GLYCOL (3350), POLYETHYLENE GLYCOL 3350, POLYETHYLENE GLYCOL 400, INSTALAX POLYETHYLENE GLYCOL 3350, NOREPINEPHRINE (BITARTRATE), NOREPINEPHRINE BITARTRATE, NOREPINEPHRINE (BITARTRATE), NOREPINEPHRINE BITARTRATE, NOREPINEPHRINE (BITARTRATE), NOREPINEPHRINE BITARTRATE, NOREPINEPHRINE (BITARTRATE), NOREPINEPHRINE BITARTRATE, NOREPINEPHRINE (BITARTRATE), NOREPINEPHRINE BITARTRATE, NOREPINEPHRINE (BITARTRATE), NOREPINEPHRINE BITARTRATE, NOREPINEPHRINE (BITARTRATE), NOREPINEPHRINE BITARTRATE, OSELTAMIVIR PHOSPHATE, OSELTAMIVIR ACID, OSELTAMIVIR, OSELTAMIVIR PHOSPHATE, OSELTAMIVIR ACID, OSELTAMIVIR, OSELTAMIVIR PHOSPHATE, OSELTAMIVIR ACID, OSELTAMIVIR, OSELTAMIVIR PHOSPHATE, OSELTAMIVIR ACID, OSELTAMIVIR, OSELTAMIVIR PHOSPHATE, OSELTAMIVIR ACID, OSELTAMIVIR, POTASSIUM CHLORATE, POTASSIUM CHLORATE, POTASSIUM CHLORATE, POTASSIUM CHLORATE, POTASSIUM CHLORATE, PYRIDOXINE HYDROCHLORIDE, PYRIDOXINE HYDROCHLORIDE, PYRIDOXINE HYDROCHLORIDE, PYRIDOXINE HYDROCHLORIDE, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, SALMETEROL XINAFOATE, SODIUM PHOSPHATE, SODIUM PHOSPHATE, THEOPHYLLINE, THEOPHYLLINE ANHYDROUS, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, VASOPRESSIN, VASOPRESSIN, VASOPRESSIN, VASOPRESSIN, VASOPRESSIN, VASOPRESSIN, VASOPRESSIN, WARFARIN SODIUM, WARFARIN, WARFARIN SODIUM, WARFARIN, WARFARIN SODIUM, WARFARIN, WARFARIN SODIUM, WARFARIN, WARFARIN SODIUM, WARFARIN, WARFARIN SODIUM, WARFARIN, WARFARIN SODIUM, WARFARIN, WARFARIN SODIUM, WARFARIN, SIMVASTATIN, SIMVASTATIN, SIMVASTATIN, SIMVASTATIN, |
||||
| 518 | 26467278 |
JP |
65 | 2 |
General physical health deterioration, Interstitial lung disease, Pneumonia, Chronic obstructive pulmonary disease, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, |
||||
| 519 | 26467460 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 520 | 26467721 |
VN |
1 | |
General physical health deterioration, |
||||
OSIMERTINIB, |
||||
| 521 | 26467815 |
US |
70 | 1 |
General physical health deterioration, Neutrophil count decreased, Fatigue, Decreased appetite, |
||||
LUTETIUM LU 177 DOTATATE, |
||||
| 522 | 26467957 |
CA |
75 | 2 |
Anxiety, Aspergillus infection, Blood immunoglobulin E increased, Decreased appetite, General physical health deterioration, Insomnia, Sensitisation, Asthma, |
||||
TRAVOPROST, TRAVOPROST (ISOMER FREE), BRINZOLAMIDE, PREDNISONE, PREDNISONE, |
||||
| 523 | 26467972 |
US |
51 | 2 |
General physical health deterioration, Pain, |
||||
ABATACEPT, |
||||
| 524 | 26468556 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 525 | 26469067 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 526 | 26469276 |
KR |
49 | 2 |
Hepatic enzyme increased, Sleep deficit, General physical health deterioration, |
||||
ABEMACICLIB, ABEMACICLIB, |
||||
| 527 | 26469537 |
EU |
83 | 2 |
Upper gastrointestinal haemorrhage, Dyspnoea, Diarrhoea, Asthenia, General physical health deterioration, Decreased appetite, Vomiting, |
||||
SOTATERCEPT-CSRK, SOTATERCEPT-CSRK, SOTATERCEPT-CSRK, SOTATERCEPT-CSRK, SOTATERCEPT-CSRK, MACITENTAN, RIOCIGUAT, FUROSEMIDE, EPLERENONE, EMPAGLIFLOZIN, INSULIN GLARGINE-YFGN, INSULIN GLARGINE, PREDNISONE, SERTRALINE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, BISOPROLOL FUMARATE, |
||||
| 528 | 26469663 |
EU |
||
Diffuse large B-cell lymphoma, General physical health deterioration, Disease progression, Drug ineffective, |
||||
GEMCITABINE HYDROCHLORIDE, GEMCITABINE, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, RITUXIMAB, RITUXIMAB, OXALIPLATIN, OXALIPLATIN, |
||||
| 529 | 26469721 |
EU |
||
Campylobacter gastroenteritis, Thrombocytopenia, Colitis, Enteritis, Immune-mediated enterocolitis, Cytomegalovirus infection reactivation, General physical health deterioration, Weight decreased, |
||||
| 530 | 26469747 |
JP |
39 | 1 |
Tumour marker increased, Malignant neoplasm progression, Thrombocytopenia, General physical health deterioration, |
||||
GEMCITABINE HYDROCHLORIDE, CISPLATIN, DURVALUMAB, |
||||
| 531 | 26469876 |
EU |
59 | 2 |
General physical health deterioration, Ischaemic stroke, Product dose omission issue, |
||||
DOSTARLIMAB, DOSTARLIMAB, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), CARBOPLATIN, |
||||
| 532 | 26473505 |
2 | ||
Application site pruritus, Therapeutic product effect decreased, Dermatitis contact, Pain in jaw, Drug ineffective, Weight decreased, Dysgeusia, Affective disorder, Dyspnoea, General physical health deterioration, Oxygen saturation decreased, COVID-19, Pneumonia, Dyspnoea exertional, |
||||
MACITENTAN, TADALAFIL, |
||||
| 533 | 26460651 |
US |
1 | |
Death, General physical health deterioration, |
||||
PIMAVANSERIN TARTRATE, CARBIDOPA AND LEVODOPA, |
||||
| 534 | 26460947 |
US |
2 | |
Pain, General physical health deterioration, Adhesive tape use, Wrong technique in product usage process, Device issue, Product adhesion issue, |
||||
| 535 | 26460995 |
CN |
79 | 2 |
Gastrointestinal haemorrhage, Interstitial lung disease, Oxygen saturation decreased, Hypotension, Unresponsive to stimuli, Chest pain, Asthenia, Somnolence, Dysuria, Urine output decreased, Abdominal distension, Abdominal pain lower, Bladder pain, Blood creatinine increased, Transaminases increased, Anaemia, Back pain, Insomnia, Blood albumin decreased, Fibrin D dimer increased, Listless, General physical health deterioration, Brain natriuretic peptide increased, Decubitus ulcer, |
||||
BEVACIZUMAB, BEVACIZUMAB, BEVACIZUMAB, BEVACIZUMAB, |
||||
| 536 | 26461186 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 537 | 26461237 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 538 | 26461284 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 539 | 26461286 |
US |
51 | 2 |
Pain, General physical health deterioration, |
||||
ABATACEPT, |
||||
| 540 | 26461625 |
US |
||
General physical health deterioration, Diarrhoea, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 541 | 26461803 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 542 | 26462079 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 DOTATATE, |
||||
| 543 | 26462267 |
US |
56 | 1 |
Drug ineffective, Product substitution issue, Product label issue, General physical health deterioration, |
||||
METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, LEVETIRACETAM, LISINOPRIL, |
||||
| 544 | 26462434 |
PE |
42 | |
Intracranial pressure increased, Brain oedema, Pneumonia, Kaposi^s sarcoma, HIV infection, General physical health deterioration, |
||||
LOPINAVIR AND RITONAVIR, EFAVIRENZ, DOXORUBICIN, ISONIAZID, RIFAMPIN, PYRAZINAMIDE, ZIDOVUDINE, LAMIVUDINE, LAMIVUDINE ORAL, CLINDAMYCIN PHOSPHATE, CLINDAMYCIN, |
||||
| 545 | 26462579 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 546 | 26462926 |
CA |
85 | 2 |
Cerebrovascular accident, Fall, General physical health deterioration, |
||||
ZOLEDRONIC ACID, ZOLEDRONIC ACID, |
||||
| 547 | 26463470 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 548 | 26463562 |
US |
57 | 2 |
Hypoxia, General physical health deterioration, Dyspnoea exertional, Drug intolerance, Fatigue, |
||||
SEMAGLUTIDE, ORAL SEMAGLUTIDE, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, SOTATERCEPT-CSRK, |
||||
| 549 | 26463616 |
EU |
1 | |
Disease progression, Anaemia, General physical health deterioration, Inappropriate schedule of product administration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 550 | 26464137 |
EU |
65 | 1 |
Influenza, General physical health deterioration, Enteral nutrition, |
||||
EMPAGLIFLOZIN, ROTIGOTINE, CARBIDOPA AND LEVODOPA, PRUCALOPRIDE, MAGNESIUM, TORSEMIDE, FOLIC ACID, AMLODIPINE, RAMIPRIL, CLOZAPINE, OLANZAPINE, MIRTAZAPINE, |
||||
| 551 | 26464235 |
US |
64 | 1 |
Cardiac pacemaker replacement, General physical health deterioration, Syncope, Oxygen saturation decreased, Bradycardia, Irregular breathing, Product use in unapproved indication, Product use issue, Inappropriate schedule of product administration, |
||||
EPOPROSTENOL SODIUM, EPOPROSTENOL SODIUM, METHYLPREDNISOLONE SODIUM SUCCINATE, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, ALBUMIN HUMAN, |
||||
| 552 | 26464455 |
CA |
45 | 2 |
Abdominal discomfort, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthropathy, Blister, Condition aggravated, Confusional state, Contusion, Discomfort, Duodenal ulcer perforation, Dyspnoea, Fatigue, Folliculitis, Gastrointestinal disorder, General physical health deterioration, Glossodynia, Hand deformity, Helicobacter infection, Hepatic enzyme increased, Hypersensitivity, Ill-defined disorder, Impaired healing, Infection, Infusion related reaction, Injury, Insomnia, Irritable bowel syndrome, Joint swelling, Lower respiratory tract infection, Muscle injury, Nasopharyngitis, Pain, Pemphigus, Pericarditis, Peripheral swelling, Pruritus, Pyrexia, Rash, Rheumatoid arthritis, Sleep disorder, Sleep disorder due to general medical condition, insomnia type, Sinusitis, Stomatitis, Swelling, Synovitis, Systemic lupus erythematosus, Weight increased, Wound, Contraindicated product administered, |
||||
ETANERCEPT, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, RITUXIMAB, TOFACITINIB, PREDNISONE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, FOSAPREPITANT DIMEGLUMINE, INFLIXIMAB, ALENDRONATE SODIUM, GOLIMUMAB, GOLIMUMAB, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CERTOLIZUMAB PEGOL, DESOXIMETASONE, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS, FOLIC ACID, ADALIMUMAB, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, LEFLUNOMIDE, ABATACEPT, OXYCODONE, OXYCODONE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, GOLIMUMAB, LEFLUNOMIDE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, |
||||
| 553 | 26464503 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 DOTATATE, |
||||
| 554 | 26464584 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 555 | 26464960 |
EU |
73 | 2 |
Mobility decreased, Pneumonia, Dysphagia, General physical health deterioration, |
||||
FOSCARBIDOPA/FOSLEVODOPA, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, RIVASTIGMINE, QUETIAPINE, |
||||
| 556 | 26464990 |
GB |
2 | |
General physical health deterioration, Crohn^s disease, |
||||
UPADACITINIB, UPADACITINIB, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, |
||||
| 557 | 26465005 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 DOTATATE, |
||||
| 558 | 26465081 |
MX |
62 | 1 |
Pleural effusion, Chronic lymphocytic leukaemia, Hypotension, General physical health deterioration, Abdominal discomfort, Bacterial abdominal infection, Pyrexia, Urinary tract infection bacterial, Chest pain, Hypotension, Nephropathy, Diarrhoea, Therapeutic product effect decreased, |
||||
VENETOCLAX, RIVAROXABAN, RIVAROXABAN, RIVAROXABAN, |
||||
| 559 | 26456968 |
US |
63 | 2 |
Dizziness, Wheezing, Headache, Vertigo, Eye pruritus, Infusion site pain, General physical health deterioration, Dyspnoea exertional, Oxygen saturation decreased, Nasal congestion, |
||||
SOTATERCEPT-CSRK, RIOCIGUAT, MACITENTAN, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, |
||||
| 560 | 26457135 |
EU |
83 | 2 |
General physical health deterioration, |
||||
| 561 | 26457543 |
EU |
1 | |
General physical health deterioration, |
||||
| 562 | 26457853 |
JP |
6 | 1 |
Malaise, Immune-mediated hepatic disorder, General physical health deterioration, |
||||
IPILIMUMAB, NIVOLUMAB, CARBOPLATIN, PEMETREXED, PEMETREXED DISODIUM, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, OXYCODONE, OXYCODONE, OXYCODONE, OXYCODONE, OXYCODONE, OXYCODONE, |
||||
| 563 | 26457877 |
JP |
||
Encephalitis, Small cell lung cancer extensive stage, Adverse event, Neutropenia, Febrile neutropenia, Aspartate aminotransferase increased, Alanine aminotransferase increased, Pneumonia, Colitis, Renal impairment, Adrenal insufficiency, Rash, Anaemia, Thrombocytopenia, General physical health deterioration, |
||||
PEGFILGRASTIM, PLATINUM, ETOPOSIDE, |
||||
| 564 | 26457916 |
US |
19 | 1 |
Lymphocyte adoptive therapy, General physical health deterioration, |
||||
PEMBROLIZUMAB, |
||||
| 565 | 26457923 |
EU |
75 | 2 |
Craniocerebral injury, General physical health deterioration, Skin laceration, Fall, Musculoskeletal stiffness, Disturbance in attention, |
||||
| 566 | 26457979 |
KR |
42 | 2 |
General physical health deterioration, Oropharyngeal pain, Dyspepsia, |
||||
NIRAPARIB, NIRAPARIB, |
||||
| 567 | 26458046 |
27 | ||
Pharyngitis streptococcal, Candida infection, Viral infection, Herpangina, Hand-foot-and-mouth disease, Oral mucosal blistering, Thrombocytopenia, Leukopenia, General physical health deterioration, Panic attack, Pain, Oral candidiasis, Gingival bleeding, Ketosis, Dehydration, Device issue, Incorrect dose administered, |
||||
BIMEKIZUMAB, |
||||
| 568 | 26458573 |
VN |
2 | |
General physical health deterioration, |
||||
OSIMERTINIB, |
||||
| 569 | 26458786 |
US |
20 | 1 |
Thrombosis, General physical health deterioration, Obesity, Hypertension, |
||||
UPADACITINIB, UPADACITINIB, |
||||
| 570 | 26459480 |
EU |
79 | 1 |
Septic shock, Diarrhoea, Adrenocortical insufficiency acute, Asthenia, General physical health deterioration, C-reactive protein increased, Pneumococcal sepsis, Weight decreased, Vomiting, |
||||
VERICIGUAT, |
||||
| 571 | 26459727 |
32 | 2 | |
Sneezing, Cough, General physical health deterioration, Cardio-respiratory arrest, Contrast media reaction, |
||||
IOPAMIDOL, |
||||
| 572 | 26459922 |
US |
76 | 1 |
Fatigue, Blood pressure increased, General physical health deterioration, Poor quality sleep, |
||||
MAVACAMTEN, LISINOPRIL, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ZOLPIDEM TARTRATE, QUETIAPINE FUMARATE, QUETIAPINE, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, ALLOPURINOL, TADALAFIL, FELODIPINE, FELODIPINE EXTENDED-RELEASE TABLETS, FAMOTIDINE, ROSUVASTATIN CALCIUM, BUPROPION HYDROCHLORIDE, AZILSARTAN KAMEDOXOMIL, HYDROCODONE BITARTRATE, AZILSARTAN KAMEDOXOMIL, SEMAGLUTIDE, ORAL SEMAGLUTIDE, FLUTICASONE PROPIONATE AND SALMETEROL, ZOLPIDEM TARTRATE, THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE, QUETIAPINE, ROSUVASTATIN, BUPROPION, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, MONTELUKAST, |
||||
| 573 | 26459949 |
EU |
37 | 2 |
Vertigo, General physical health deterioration, Gastrointestinal disorder, |
||||
ADALIMUMAB, |
||||
| 574 | 26459992 |
CA |
64 | 1 |
Arthropathy, Malignant melanoma, Melanocytic naevus, Pain in extremity, Respiratory rate increased, Weight decreased, General physical health deterioration, Blood pressure increased, Blood pressure systolic increased, Weight increased, Heart rate decreased, Inappropriate schedule of product administration, Prescribed overdose, |
||||
CELECOXIB, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, AMLODIPINE, FLUTICASONE FUROATE, CALCIUM, DOXAZOSIN MESYLATE, ERGOCALCIFEROL, FOLIC ACID, HYDROXYCHLOROQUINE SULFATE, METHOTREXATE, METHOTREXATE SODIUM, PANTOPRAZOLE, PREDNISONE, ROSUVASTATIN CALCIUM, |
||||
| 575 | 26460052 |
EU |
26 | 1 |
Aphthous ulcer, Dysphagia, General physical health deterioration, Weight decreased, Oropharyngeal pain, Inflammatory marker increased, Crohn^s disease, Pancytopenia, Pyrexia, Gastritis, Chromaturia, Gastrointestinal wall thickening, Abdominal pain, Off label use, |
||||
CYCLOSPORINE, CYCLOSPORINE, IPTACOPAN, IPTACOPAN, CYCLOSPORINE, CYCLOSPORINE, ELTROMBOPAG OLAMINE, ELTROMBOPAG, ELTROMBOPAG OLAMINE, ELTROMBOPAG, PROPOFOL, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, CYCLOSPORINE, MAGNESIUM OXIDE, TRANEXAMIC ACID, TRANEXAMIC ACID, CANDESARTAN, FOLIC ACID, MESALAMINE, ELTROMBOPAG, ELTROMBOPAG OLAMINE, |
||||
| 576 | 26460063 |
CA |
66 | 2 |
Abdominal pain upper, Asthenia, Constipation, Dehydration, Diarrhoea, Dizziness, Dyspepsia, Dysphonia, Dyspnoea, Electrolyte imbalance, Faecaloma, Fatigue, Feeding disorder, Flank pain, General physical health deterioration, Nausea, |
||||
DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN, RITUXIMAB, VINCRISTINE SULFATE, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, IBRUTINIB, PREDNISONE, |
||||
| 577 | 26460095 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 578 | 26460496 |
US |
2 | |
General physical health deterioration, |
||||
TEDUGLUTIDE, TEDUGLUTIDE, TEDUGLUTIDE, TEDUGLUTIDE, ZOLPIDEM TARTRATE, ERGOCALCIFEROL, USTEKINUMAB, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, AMITRIPTYLINE HYDROCHLORIDE, CLONIDINE HYDROCHLORIDE, ALPRAZOLAM, HYOSCYAMINE SULFATE, PROMETHAZINE HYDROCHLORIDE, I.V. FAT EMULSION, I. V. FAT EMULSION, OXYCODONE HYDROCHLORIDE, OXYCODONE, |
||||
| 579 | 26452992 |
CA |
||
Hypocholesterolaemia, Impaired healing, Infusion related reaction, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Lung disorder, Memory impairment, Glossodynia, Folliculitis, Weight increased, Vomiting, Taste disorder, Synovitis, Rash, Peripheral venous disease, Peripheral swelling, Paraesthesia, Pain, Night sweats, Muscle spasms, Migraine, Abdominal discomfort, Abdominal pain upper, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Blepharospasm, Blister, Blood cholesterol increased, Decreased appetite, Depression, Diarrhoea, Dizziness, Dry mouth, Gastrooesophageal reflux disease, General physical health deterioration, Headache, Hepatic enzyme increased, Contraindicated product administered, Maternal exposure during pregnancy, Product quality issue, |
||||
RITUXIMAB, LORAZEPAM, QUETIAPINE FUMARATE, QUETIAPINE, RISEDRONATE SODIUM, LISINOPRIL, FISH OIL, |
||||
| 580 | 26453241 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 581 | 26453433 |
US |
53 | 2 |
General physical health deterioration, |
||||
APREPITANT, FOSAPREPITANT DIMEGLUMINE, |
||||
| 582 | 26453485 |
BR |
59 | 2 |
Frustration tolerance decreased, General physical health deterioration, Device malfunction, Device failure, Drug dose omission by device, Hyperphagia, Off label use, Wrong technique in product usage process, |
||||
SEMAGLUTIDE, SEMAGLUTIDE, |
||||
| 583 | 26453806 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 584 | 26453888 |
EU |
47 | 2 |
Rash, Pruritus, Illness, Alopecia, Scab, Dermatitis, Eczema, Dandruff, Influenza, Impaired work ability, General physical health deterioration, |
||||
ERGOCALCIFEROL, HYDROCORTISONE, |
||||
| 585 | 26453900 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 586 | 26453924 |
CA |
75 | 1 |
General physical health deterioration, Immunosuppression, Inappropriate schedule of product administration, Lower limb fracture, Nasopharyngitis, Osteoporosis, Tibia fracture, |
||||
RITUXIMAB, RITUXIMAB, |
||||
| 587 | 26453994 |
EU |
54 | 2 |
Multiple organ dysfunction syndrome, Plasma cell myeloma, Mobility decreased, General physical health deterioration, Pain, Haemoptysis, Febrile neutropenia, |
||||
CEFTRIAXONE, CEFTRIAXONE SODIUM, MEROPENEM, |
||||
| 588 | 26454030 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 589 | 26454387 |
EU |
64 | 1 |
Septic shock, General physical health deterioration, Abdominal symptom, Hypogammaglobulinaemia, Plasma cell myeloma refractory, |
||||
TECLISTAMAB-CQYV, ZOLEDRONIC ACID, DENOSUMAB, |
||||
| 590 | 26454730 |
CA |
44 | 2 |
Stomatitis, Sinusitis, Sleep disorder, Sleep disorder due to general medical condition, insomnia type, Swelling, Swollen joint count increased, Synovitis, Systemic lupus erythematosus, Therapeutic product effect decreased, Therapy non-responder, Treatment failure, Type 2 diabetes mellitus, Urticaria, Vomiting, Weight increased, Rash, Wheezing, Wound, Joint swelling, Abdominal pain, Abdominal pain upper, Adverse drug reaction, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Anxiety, Arthralgia, Arthropathy, Asthenia, Asthma, Autoimmune disorder, Blister, Blood cholesterol increased, Bursitis, C-reactive protein abnormal, Chest pain, Condition aggravated, Confusional state, Contraindicated product administered, Contusion, Decreased appetite, Deep vein thrombosis postoperative, Diarrhoea, Discomfort, Dizziness, Drug hypersensitivity, Drug ineffective, Drug intolerance, Dry mouth, Duodenal ulcer perforation, Dyspnoea, Exposure during pregnancy, Facet joint syndrome, Fatigue, Fibromyalgia, Folliculitis, Gait inability, Gastrointestinal disorder, General physical health deterioration, Glossodynia, Hand deformity, Hand deformity, Headache, Helicobacter infection, Hepatic cirrhosis, Hepatic enzyme increased, Hypersensitivity, Hypertension, Hypoaesthesia, Ill-defined disorder, Impaired healing, Infection, Inflammation, Infusion related reaction, Injury, Insomnia, Intentional product use issue, Irritable bowel syndrome, Joint dislocation, Joint range of motion decreased, Lip dry, Liver disorder, Liver injury, Lower limb fracture, Lower respiratory tract infection, Lung disorder, Malaise, Maternal exposure during pregnancy, Maternal exposure timing unspecified, Medication error, Mobility decreased, Muscle injury, Muscle spasms, Musculoskeletal pain, Musculoskeletal stiffness, Nasopharyngitis, Night sweats, Obesity, Oedema, Oedema peripheral, Off label use, Osteoarthritis, Pain, Paraesthesia, Pemphigus, Pericarditis, Peripheral swelling, Peripheral venous disease, Pregnancy, Prescribed overdose, Product use in unapproved indication, Product use issue, Pruritus, Psoriatic arthropathy, Pyrexia, Rheumatic fever, Rheumatoid arthritis, Rheumatoid factor positive, Road traffic accident, Sciatica, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, OXYCODONE, OXYCODONE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, ADALIMUMAB-ADAZ, OXYCODONE HYDROCHLORIDE, OXYCODONE, ALENDRONATE SODIUM, ALENDRONATE SODIUM, AZATHIOPRINE, CELECOXIB, CELECOXIB, ALENDRONATE SODIUM, ALENDRONATE SODIUM, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, SECUKINUMAB, LEFLUNOMIDE, LEFLUNOMIDE, VITAMIN C, CALCIUM CARBONATE, ANTACID, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CALCIUM GLUCONATE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, CORTISONE ACETATE, CORTISONE ACETATE, DEXTROMETHORPHAN, DEXTROMETHORPHAN, GOLIMUMAB, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, ADALIMUMAB, ADALIMUMAB, HYDROCORTISONE BUTYRATE, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, ERGOCALCIFEROL, MORPHINE SULFATE, OXYCODONE AND ACETAMINOPHEN, OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, OXYCODONE AND ACETAMINOPHEN TABLETS, LISINOPRIL, LISINOPRIL, RAMIPRIL, SULFASALAZINE, TOFACITINIB, LANSOPRAZOLE, LANSOPRAZOLE, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, LORAZEPAM, TRIMETHOPRIM, CAFFEINE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, ERGOCALCIFEROL, ERGOCALCIFEROL, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, ACETAMINOPHEN AND CODEINE, ACETAMINOPHEN AND CODEINE, LORAZEPAM, LORAZEPAM, |
||||
| 591 | 26454769 |
FK |
40 | 2 |
Exposure during pregnancy, Gastrointestinal disorder, Live birth, Lower respiratory tract infection, Joint swelling, Wound, Alopecia, Hypertension, Drug ineffective, Type 2 diabetes mellitus, Therapeutic product effect decreased, Product label confusion, Muscular weakness, Nausea, Arthralgia, Treatment failure, C-reactive protein abnormal, Injury, Product use issue, Hepatic enzyme increased, Drug hypersensitivity, Pneumonia, Rheumatoid arthritis, General physical health deterioration, Hypersensitivity, Systemic lupus erythematosus, Blood cholesterol increased, Stomatitis, Hepatitis, Insomnia, Synovitis, Abdominal discomfort, Abdominal distension, Adverse reaction, Anti-cyclic citrullinated peptide antibody positive, Arthropathy, Coeliac disease, Condition aggravated, Contraindicated product administered, Drug intolerance, Drug-induced liver injury, Dyspepsia, Fatigue, Gastrointestinal disorder, Glossodynia, Grip strength decreased, Hand deformity, Headache, Hepatic enzyme increased, Hypersensitivity, Loss of personal independence in daily activities, Infusion related reaction, Injection site reaction, Malaise, Musculoskeletal stiffness, Nail disorder, Off label use, Onychomadesis, Onychomycosis, Pain, Pemphigus, Pericarditis, Product use in unapproved indication, Psoriatic arthropathy, Rheumatic fever, Rash, Sleep disorder, Swelling, Maternal exposure during pregnancy, Vomiting, Pain in extremity, Back injury, C-reactive protein increased, Gait inability, Confusional state, Fall, Finger deformity, Neck pain, Inflammation, Liver function test increased, Mobility decreased, Therapeutic product effect incomplete, Impaired healing, Folliculitis, Synovitis, Blister, Overdose, Duodenal ulcer perforation, Ill-defined disorder, Contusion, Helicobacter infection, Dyspnoea, Memory impairment, Migraine, Muscle injury, Muscle spasms, Musculoskeletal pain, Nasopharyngitis, Night sweats, Obesity, Joint range of motion decreased, Irritable bowel syndrome, Lung disorder, Depression, Asthenia, Diarrhoea, Dizziness, Dry mouth, Epilepsy, Breast cancer stage III, Facet joint syndrome, Fibromyalgia, Hypercholesterolaemia, Abdominal pain upper, Blepharospasm, Liver injury, Decreased appetite, Bursitis, Gastrooesophageal reflux disease, Hypoaesthesia, Intentional product use issue, Underdose, Overdose, Lip dry, Osteoarthritis, Paraesthesia, Peripheral swelling, Peripheral venous disease, Taste disorder, Urticaria, Weight increased, Wheezing, Wound infection, Nasopharyngitis, Product quality issue, Incorrect product administration duration, Skin reaction, Bronchitis, Eye injury, Psoriasis, Tachycardia, Ulcer haemorrhage, Upper respiratory tract infection, White blood cell count decreased, Loss of personal independence in daily activities, Hypotension, Normal newborn, Asthma, Dislocation of vertebra, Hepatic cirrhosis, Infusion site reaction, Infection, Joint stiffness, Laryngitis, Liver disorder, Lower limb fracture, Lupus-like syndrome, Oedema, Pulmonary fibrosis, Pyrexia, Red blood cell sedimentation rate increased, Rheumatoid factor positive, Respiratory disorder, Sciatica, Sleep disorder due to general medical condition, hypersomnia type, Sinusitis, Exostosis, Gait disturbance, Incorrect route of product administration, Medication error, Oedema peripheral, Osteoporosis, Prescribed underdose, Swollen joint count increased, Therapy non-responder, Weight decreased, Discomfort, Prescribed overdose, X-ray abnormal, Product label confusion, Product quality issue, Product use in unapproved indication, Product use issue, Anxiety, Autoimmune disorder, Hepatobiliary disease, Deep vein thrombosis postoperative, Nervous system disorder, Poisoning, |
||||
NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, TRAMADOL HYDROCHLORIDE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, APREMILAST, APREMILAST, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, GOLD, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, APREMILAST, APREMILAST, APREMILAST, APREMILAST, APREMILAST, APREMILAST, MINOCYCLINE HYDROCHLORIDE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SARILUMAB, USTEKINUMAB, USTEKINUMAB, USTEKINUMAB, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, MINOCYCLINE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, METHYLPREDNISOLONE, METHYLPREDNISOLONE, TETRACYCLINE HYDROCHLORIDE, MINOCYCLINE HYDROCHLORIDE, MINOCYCLINE HYDROCHLORIDE, AZATHIOPRINE SODIUM, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, AZATHIOPRINE, TRAMADOL HYDROCHLORIDE, ALENDRONATE SODIUM, ALENDRONATE SODIUM TABLET, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, MEPOLIZUMAB, CALCIUM CARBONATE, ANTACID, NAPROXEN, NAPROXEN SODIUM, ETANERCEPT, SARILUMAB, DEXTROMETHORPHAN, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, ZINC, ZINC GLUCONATE, ZINC CHLORIDE, LAMOTRIGINE, LAMOTRIGINE, LAMOTRIGINE, LAMOTRIGINE, ERENUMAB-AOOE, ERENUMAB-AOOE, ERENUMAB-AOOE, OXYCODONE, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ATOMOXETINE, CANDESARTAN, CANDESARTAN, CANDESARTAN, PHENYLEPHRINE HYDROCHLORIDE, PHENYLEPHRINE HYDROCHLORIDE, BUPRENORPHINE, MIRABEGRON, MIRABEGRON, VITAMIN C, CELECOXIB, CELECOXIB, BOTULINUM TOXIN TYPE A, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, RAMIPRIL, RAMIPRIL, RAMIPRIL, RAMIPRIL, RANITIDINE, USTEKINUMAB, USTEKINUMAB, USTEKINUMAB, ERGOCALCIFEROL, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, DICLOFENAC SODIUM, RITUXIMAB-ABBS, RITUXIMAB-ABBS, RITUXIMAB-ABBS, RITUXIMAB-ABBS, RITUXIMAB-ABBS, RITUXIMAB-ABBS, RITUXIMAB-ABBS, RITUXIMAB-ABBS, RITUXIMAB-ABBS, RITUXIMAB-ABBS, RITUXIMAB-ABBS, RITUXIMAB-ABBS, RITUXIMAB-ABBS, RITUXIMAB-ABBS, RITUXIMAB-ABBS, RITUXIMAB-ABBS, RITUXIMAB-ABBS, RITUXIMAB-ABBS, RITUXIMAB-ABBS, RITUXIMAB-ABBS, RITUXIMAB-ABBS, RITUXIMAB-ABBS, RITUXIMAB-ABBS, RITUXIMAB-ABBS, RITUXIMAB-ABBS, RITUXIMAB-ABBS, RITUXIMAB-ABBS, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, ERENUMAB-AOOE, ACETAMINOPHEN AND CODEINE, ACETAMINOPHEN AND CODEINE, ATOMOXETINE HYDROCHLORIDE, ATOMOXETINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE, ACETAMINOPHEN AND CODEINE, HYDROCORTISONE BUTYRATE, HYDROXYCHLOROQUINE SULFATE, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, TETRACYCLINE HYDROCHLORIDE, TETRACYCLINE HYDROCHLORIDE, NAPROXEN, NAPROXEN SODIUM, DESOGESTREL AND ETHINYL ESTRADIOL, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, CERTOLIZUMAB PEGOL, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, MAGNESIUM CHLORIDE, POVIDONE-IODINE, ERGOCALCIFEROL, LEFLUNOMIDE, NICOTINAMIDE, |
||||
| 592 | 26454788 |
BY |
2 | |
Hydrothorax, Condition aggravated, General physical health deterioration, |
||||
LORLATINIB, |
||||
| 593 | 26455067 |
CA |
79 | 2 |
Hospitalisation, Weight decreased, General physical health deterioration, Lymphoedema, Decreased appetite, Urinary tract infection, Paraesthesia oral, Hypogeusia, Hypertension, Glossodynia, Tongue pruritus, Pain in extremity, Nausea, Asthenia, Dizziness, |
||||
NABILONE, BELIMUMAB, BELIMUMAB, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, PREDNISONE, DESOXIMETASONE, HYDROXYCHLOROQUINE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, |
||||
| 594 | 26455968 |
HN |
2 | |
General physical health deterioration, Incorrect dose administered, |
||||
INSULIN HUMAN, INSULIN HUMAN, |
||||
| 595 | 26455999 |
CA |
71 | 1 |
Hypertension, General physical health deterioration, Hypoacusis, |
||||
RITUXIMAB, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, METHYLPREDNISOLONE, |
||||
| 596 | 26456075 |
EU |
2 | |
General physical health deterioration, Metastases to peritoneum, Ascites, |
||||
RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, LETROZOLE, LETROZOLE TABLETS, LETROZOLE, LETROZOLE TABLETS, LETROZOLE, LETROZOLE TABLETS, |
||||
| 597 | 26456525 |
US |
63 | 2 |
Asphyxia, Victim of homicide, Cardiomegaly, Drug screen positive, Lung disorder, General physical health deterioration, Stress, |
||||
HYDROCODONE BITARTRATE, ALCOHOL, ISOPROPYL ALCOHOL, |
||||
| 598 | 26448531 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 599 | 26448603 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 600 | 26448623 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-04-28